Norges Bank Harmony Biosciences Holdings, Inc. Transaction History

Norges Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$28.81 - $33.01 $3.69 Million - $4.22 Million	127,988 New	127,988 $3.86 Million
Q4 2023 Feb 09, 2024	BUY	$19.2 - $33.78 $3.41 Million - $6 Million	177,558 New	177,558 $5.74 Million
Q3 2023 Nov 13, 2024	BUY	$31.89 - $39.03 $6.07 Million - $7.43 Million	190,328 New	190,328 $6.24 Million
Q3 2023 Nov 13, 2023	SELL	$31.89 - $39.03 $11.5 Million - $14.1 Million	-361,027 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$30.5 - $37.4 $1.9 Million - $2.33 Million	62,340 Added 48.71%	190,328 $6.7 Million
Q1 2023 May 15, 2024	BUY	$30.8 - $53.92 $6.97 Million - $12.2 Million	226,228 New	226,228 $7.39 Million
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $10.9 Million - $14.6 Million	240,227 New	240,227 $13.2 Million
Q3 2022 Nov 13, 2023	BUY	$42.06 - $55.45 $15.2 Million - $20 Million	361,027 New	361,027 $16 Million
Q3 2021 Nov 05, 2021	SELL	$25.68 - $38.61 $1.87 Million - $2.81 Million	-72,800 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$25.96 - $33.44 $1.89 Million - $2.43 Million	72,800 New	72,800 $2.06 Million

242

45.2M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.94B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.